Medical Condition News

RSS

Update on the status of Somaxon Pharmaceuticals' NDA for Silenor provided

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.

22 Jan 2010

Findings may aid in developing therapeutic drugs for stroke and other neurodegenerative diseases

Biomedical scientists from the University of Central Florida and Louisiana State University have identified a way to block a "cell death signal" that they believe triggers brain damage during strokes.

22 Jan 2010

Mice study shows obesity can increase risk of developing liver cancer

Obesity comes with plenty of health risks, but there's one that's perhaps not so well known: an increased risk of developing cancer, and especially certain types of cancer like liver cancer. Now, a group of researchers reporting in the January 22nd issue of the journal Cell, a Cell Press publication, have confirmed in mice that obesity does indeed act as a "bona fide tumor promoter." They also have good evidence to explain how that happens.

22 Jan 2010

FDA accepts ACT Biotech's ACTB1003 IND

ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, today announced the acceptance of the Investigational New Drug (IND) application for ACTB1003 by the US Food and Drug Administration (FDA). The company has now assembled a complete preclinical package, including manufacturing and toxicology studies, allowing ACTB1003 to enter a clinical trial.

22 Jan 2010

Consistent pattern of cognitive deficits during childhood leads to adult schizophrenia

Years before adults develop schizophrenia, there is a pattern of cognitive difficulties they experience as children, including problems with verbal reasoning, working memory, attention and processing speed.

22 Jan 2010

Tips to identify signs of eating disorders

It's estimated that one-third of Americans made a New Year's resolution to lose weight this year. Though these dieting individuals may have healthy intentions, they could be putting themselves at risk for an eating disorder, warns Eating Recovery Center (www.eatingrecoverycenter.com), a licensed and Joint Commission accredited behavioral hospital providing comprehensive treatment and sustainable recovery for eating disorders.

22 Jan 2010

Study identifying new form of adult onset muscular dystrophy published

A study published in today's online edition the American Journal of Human Genetics, allowed the first identification of a new form of adult onset muscular dystrophy.

22 Jan 2010

Quitting smoking doubles survival chances in lung cancer patients

People diagnosed with early stage lung cancer can double their chances of survival over five years if they stop smoking compared with those who continue to smoke, finds a study published on bmj.com today.

22 Jan 2010

Association between vitamin D and risk of colorectal cancer identified

High blood levels of vitamin D are associated with a lower risk of colon cancer, finds a large European study published on bmj.com today. The risk was cut by as much as 40% in people with the highest levels compared with those in the lowest.

22 Jan 2010

Reducing dietary salt can offer significant health benefits

Reducing salt in the American diet by as little as one-half teaspoon (or three grams) per day could prevent nearly 100,000 heart attacks and 92,000 deaths each year, according to a new study. Such benefits are on par with the benefits from reductions in smoking and could save the United States about $24 billion in healthcare costs, the researchers add.

21 Jan 2010

VNSNY receives funding for testing IT strategies to aid elderly cognitive impairment patients

The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.

21 Jan 2010

Behavioral Innovations opens its first autism treatment center in Texas

Behavioral Innovations, the premier provider of Applied Behavior Analysis (ABA) services for families of children with autism and other developmental disorders, today announces the opening of its San Antonio location, which will begin offering services February 1. The company is in the process of expanding to Fort Worth and Wichita Falls where they will begin serving families in early spring.

21 Jan 2010

Cancer Research UK offers translation service for people affected by cancer

Thanks to a partnership with Language Line - who interpret telephone conversations in over 170 languages - people affected by cancer who need an interpreter can now have their questions answered.

21 Jan 2010

FDA approves continuous-flow heart-assist device pioneered at Texas Heart Institute at SLEH

The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke’s Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.

21 Jan 2010

Scientific/technical review for XIAFLEX' European MAA commences

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.

21 Jan 2010

Five questions for successful weight loss

The American Society of Bariatric Physicians (ASBP) works with physicians so they’re better prepared to deal with society’s obesity epidemic. Even though people focus on weight loss more in January than any other month, successful weight loss is a year-round long-term initiative that goes far beyond just diet and exercise. The ASBP has highlighted five questions everyone who needs to lose weight should ask their physician.

21 Jan 2010

University of Miami psychologists use non-expert student observers in autism research

Non-expert is not often a term that one would associate with scientific research, but it could become a new trend in psychology research. Some recent studies have begun to rely on non-expert students to observe and provide data during experiments.

21 Jan 2010

Data demonstrates overall radiation with digital mammography is less than film mammography

Data from one of the largest mammography trials in history demonstrates that overall the radiation dose associated with digital mammography is significantly lower (averaging 22 percent lower) than that of conventional film mammography and that the reduction could be greater in women with larger and denser breasts, according to a study published in the February issue of the American Journal of Roentgenology.

21 Jan 2010

US FDA grants tentative approval for LPI's Memantine HCl tablets

Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received tentative approval from the US Food and Drug Administration (US FDA) for its Memantine Hydrochloride tablets, 5mg and 10mg.

21 Jan 2010

World’s first Cs-131 implant for colorectal cancer performed at Weill Cornell Medical Center

IsoRay, Inc., announced today that on October 10, 2009, Dr. Bhupesh Parashar, Dr. A Gabriella Wernicke and Dr. KS Clifford Chao from the Department of Radiation Oncology, and Dr. Jeffery Milsom from the Department of Gastrointestinal Surgery, at Weill Cornell Medical Center performed the world’s first Cesium-131(Cs-131) implant for the treatment of colorectal cancer.

21 Jan 2010